Susquehanna International Group’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.28M | Buy |
|
|||||
|
2024
Q3 | $1.25M | Buy |
|
|||||
|
2024
Q2 | $656K | Buy |
|
|||||
|
2024
Q1 | $502K | Sell |
|
|||||
|
2023
Q4 | $842K | Buy |
|
|||||
|
2023
Q3 | $312K | Sell |
|
|||||
|
2023
Q2 | $1.08M | Buy |
|
|||||
|
2023
Q1 | $1.06M | Buy |
|
|||||
|
2022
Q4 | $259K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $652K | Sell |
|
|||||
|
2022
Q1 | $1.39M | Buy |
|
|||||
|
2021
Q4 | $755K | Sell |
|
|||||
|
2021
Q3 | $1.44M | Buy |
|
|||||
|
2021
Q2 | $1.04M | Buy |
|
|||||
|
2021
Q1 | $516K | Sell |
|
|||||
|
2020
Q4 | $935K | Buy |
|
|||||
|
2020
Q3 | $379K | Sell |
|
|||||
|
2020
Q2 | $567K | Sell |
|
|||||
|
2020
Q1 | $644K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $568K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.13M | Buy |
|
|||||
|
2017
Q2 | $469K | Buy |
|